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Women experience fluctuating sex hormone concentrations throughout their lifetime 
and while their role in reproduction is well documented, there is little knowledge of the 
effects of the changing hormone concentrations on women’s cerebrovascular health. 
Therefore, this study examined dynamic cerebral autoregulation (dCA) in 10 healthy 
eumenorrheic women (28 ± 7 years) volunteers. The participants dCA was examined at three 
different phases of the menstrual cycle: early follicular (EF; when oestrogen and progesterone 
concentrations are low), late follicular (LF; oestrogen concentrations are high, while 
progesterone remains steady), and mid-luteal (ML; oestrogen and progesterone 
concentrations are high). The dCA was assessed using the autoregulatory index (AI) of forced 
changes in blood pressure (BP) and mean middle cerebral blood velocity (MCAv) response, 
induced during phases of the Valsalva manoeuvre (VM). The VM is a four-phase manoeuvre 
that produces hyper- and hypotensive changes to blood pressure (BP): phase I (initial increase 
in BP), phase IIa (initial decrease in BP), phase IIb (stabilisation of BP), phase III (decrease in 
BP after cessation of breath-hold), and phase IV (overshoot in BP recovery).  Resting mean 
arterial blood pressure (MAP, P= 0.409), MCAv (P= 0.635), and cerebrovascular conductance 
index (CVCi, P= 0.984) were not different throughout all trials. The partial pressure of end-
tidal carbon dioxide (PETCO2) was unchanged between the trials (P = 0.907).  The VM induced 
middle cerebral artery velocity mean (MCAvmean) differences between trials (interaction: P = 
0.039), MCAv during mid-luteal (ML; 58 ± 15 cm/s) showed a significant difference to early 
follicular (EF; 51 ± 14 cm/s, P = 0.013) and late follicular (LF; 49 ± 15 cm/s, P = 0.024) during 
phase IIb of the VM. There were no differences in MAP (P = 0.233) and CVCi (P = 0.808) during 
the VM throughout the trials. AI presented no difference during phase II of the VM (P= 0.354), 
however, phase IV did show a trend (P= 0.086). The results of this study indicate that 
circulating ovarian hormone concentrations may regulate responses to dynamic 





This thesis report is submitted for the requirement of the degree of Master of Science 
(MSc) at Massey University, Wellington. This thesis was completed in April 2020 under the 
supervision of Dr Blake Perry from the School of Health Sciences, Associate Professor Toby 
Mundel from the School of Sport, Exercise and Nutrition, and Dr Sally Lark, previously of 
School of Sport, Exercise and Nutrition. This research was put forward to investigate and gain 
further knowledge on the effects of oestrogen on cerebrovascular regulation in eumenorrheic 
women. 
There were complications with data collection, as the equipment required for the 
study was not available at the beginning of the study. Furthermore, like many in vivo human 
studies, there were participants unable to complete all trials. This was impacted further by 
the COVID-19 virus, which ended any attempt to collect more data or recruit participants. If 
original participants completed all trials, our numbers would have been ten instead of seven.   
Additional data such as posterior cerebral artery blood velocity, transfer function 
analysis of spontaneous (resting) and forced (sit-to-stand manoeuvres and thigh cuff release) 
blood pressure oscillation was recorded during the study. The aforementioned data will be 
analysed and presented in a more detailed manuscript submitted for publication at a later 
date. For the purpose of this thesis, the candidate and supervisors decided to focus on the 
MCA as previous studies have used this artery as their main cerebral vessel. Furthermore, the 
decision to examine the VM, which is a well-recognised method for challenging cerebral 
autoregulation, would allow comparisons with existing literature. 
There have been few studies investigating the effects of oestrogen and the menstrual 
cycle on cerebrovascular regulation, despite the knowledge that ovarian hormones can alter 
arterial vascular tone. Existing literature had poor control in regard to the timing of data 
collection throughout the menstrual cycle. Timing is paramount given the variability in 
individual cycle duration and frequency of ovulation. This study was designed to investigate 
the effects of oestrogen on cerebrovascular regulation in healthy female participants. As the 
candidate, I prepared the entire ethics application and gained the ethical approval needed for 
the research. I was solely responsible for the recruitment participants from Massey 
University, Wellington, as well as the wider Wellington area. Data collection for this thesis, 
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and the additional measures not included herein, was completed by Dr Perry and I (candidate 
contribution = 75%), and took place in a laboratory at Massey University, Wellington.  I 
completed data analysis (100%) and statistical analysis (100%) under guidance of the 
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Chapter One: Introduction 
 
The brain, like many other organs in the body, requires adequate blood flow to be able 
to carry out normal function. Despite the brain only making up 2 – 3% of the body’s entire 
mass, it needs approximately 15% of total cardiac output and approximately 20% of total 
oxygen consumption (Willie, Tzeng, Fisher, & Ainslie, 2014).  Furthermore, despite the high 
metabolic rate, the brain does not store any energy substrate (Brown & Ransom, 2007) and 
therefore requires a constant supply of blood that is tightly regulated to allow adequate 
nutrient supply and metabolic waste removal. Brain blood supply is indirectly measured as 
variation in blood pressure. Cerebral perfusion pressure (CPP) is defined as the difference 
between MAP and intracranial pressure (ICP; CPP = MAP – ICP) (Smith, Clayton, & Robertson, 
2011). Given that simple manoeuvres such as standing can rapidly decrease MAP, and 
therefore CPP, it is imperative that the brain can respond quickly to changes in MAP to 
maintain adequate perfusion. Even short periods of reduced perfusion can lead to 
unconsciousness (Van Lieshout, Wieling, Karemaker, & Secher, 2003), brain damage, and 
death if CPP does not return to normal (Smith, Clayton, & Robertson, 2011). As a means of 
protection against stresses such as changes to arterial blood pressure (ABP), neuronal 
metabolism, and autonomic nervous system (ANS), the brain has an array of regulatory 
mechanisms that interact with each other to enable adequate blood flow (Willie et al., 2014). 
An important mechanism involved in maintaining adequate cerebral blood flow (CBF) is 
cerebral autoregulation (CA). This mechanism is important in defending the brain against 
changes in blood pressure and works by altering the diameter of arterial blood vessels, thus 
controlling blood flow in the brain (Fantini, Sassaroli, Tgavalekos, & Kornbluth, 2016). Lassen 
(1959) stated that CA could defend blood pressure changes between the MAP ranges of 60 – 
150 mm Hg. However, Tan (2012) found that the effective range is much narrower than 
previously thought (Figure 3).  
CA is not the only mechanism that can alter cerebral vessel diameter. Sex hormones 
can alter arterial vessel diameter under different physiological and pathological conditions 
(Robison, Gannon, Salinero, & Zuloaga, 2019) in both females and males. Due to the different 
concentrations of circulating sex hormones, there are differences in CBF and CA between 
females and males  (Krause, Duckles, & Pelligrino, 2006). Reports have shown that male sex 
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hormones induce vasoconstriction in cerebral vessels, thus decreasing CBF (Geary, Krause, & 
Duckles, 1998). However, the effects of female ovarian hormones are complicated. Krejza et 
al. (2003) found that during the late follicular phase when oestrogen concentrations are at 
their highest and progesterone concentrations are unchanged (steady), they saw an increase 
in cerebral blood flow velocity (CBFv) in the internal carotid artery (ICA), thus highlighting the 
vasodilatory ability of oestrogen (when no other regulatory mechanism is acting upon the 
vessel). During mid-luteal phase a reduction in CBFv was seen, which implies that there is 
relationship between cerebrovascular resistance (CVR) and progesterone concentrations 
(Krejza, Mariak, Nowacka, Melhem, & Babikian, 2004). Therefore, the fluctuating sex 
hormone concentrations during menstrual cycle, could have adverse effects on the female 
cerebral circulation and CA.  
Abidi et al. (2017), who examined the effects of the Valsalva manoeuvre (VM) and 
orthostasis on CA during the follicular phase (low oestrogen and progesterone 
concentrations) and the mid-luteal phase (high oestrogen and progesterone concentrations) 
of the menstrual cycle. The authors found that during the mid-luteal phase, women displayed 
a greater tendency towards vasoconstriction during the VM and orthostasis when compared 
to men. There were no differences between oral contraception users and non-oral 
contraceptive users. Furthermore, in contrast Favre and Serrador (2019) found that there was 
no difference in CA in healthy women who were not on any form of contraception across the 
menstrual cycle, see Section 2.15 for further discussion. 
The lack of research is due to the additional difficulty of requiring testing to be 
completed at more than one time point to account for the changes in hormones. 
Furthermore, external factors such as stress, diet, and exercise can modify the menstrual 
cycle. A factor that further complicates the studies on the menstrual cycle is that a significant 
proportion of women of reproductive age are using contraception, which can alter hormone 
concentrations. Research with women on contraception provides important information, 
however, it does not provide information in regard to the natural occurring variations in 
women ovarian hormones. 
Increasing the understanding of the effects of female ovarian hormones is of particular 
importance because there is a significant increase in the incidence of stroke in women after 
menopause (Lisabeth & Bushnell, 2012). Due to menopausal women having low oestrogen 
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concentrations, it is plausible that oestrogen has a regulatory role and a possible protective 
mechanism in cerebrovascular function. There is very little scientific investigation on 
cerebrovascular function in healthy eumenorrheic women. A previous study by Abidi et al. 
(2017) reported that female ovarian hormones could potentially play a role in cerebrovascular 
function in response to changes in ABP. However, the authors of this study only investigated 
the low oestrogen and progesterone phase against the high oestrogen and progesterone 
phase, therefore, it is difficult to isolate which hormone is eliciting the response seen in the 
study.  
 The objective of this thesis was to investigate the potential regulatory role of female 
ovarian hormones in cerebrovascular regulation by comparing cerebrovascular responses 
throughout the menstrual cycle in eumenorrheic women. This thesis aims to assist in 
improving the understanding of female ovarian hormones on CBF regulation by examining 
healthy female individuals who are not using oral contraceptives, hormonal contraception, 
and implant or intra uterine devices (IUD), during the VM. By furthering our understanding 
on the role that these hormones play on cerebrovascular function in healthy eumenorrheic 
women, future studies can investigate the physiological impact when endogenous hormones 
are altered naturally or pharmacologically. The hypothesis for this investigation was that 
during the high oestrogen phase (late follicular) of the menstrual cycle, female participants 
would demonstrate a blunted response in dynamic cerebrovascular autoregulation compared 




Chapter Two: Literature Review 
 
2.1 Cerebral Blood Flow  
The human brain accounts for ~2% of total body mass but receives close to 15% of 
cardiac output (Q) and is responsible for ~20% of the body’s oxygen consumption (Willie et 
al., 2011) due to an extraordinarily high metabolism. As there are no energy stores in the 
brain (Brown & Ransom, 2007), energy substrate needs to be continuously delivered to the 
brain,  thus resulting in precise CBF regulation (Willie et al., 2011; Willie et al., 2014). Any 
significant changes to CBF such as inadequate perfusion (hypoperfusion) or excess perfusion 
(hyperperfusion) can result in severe brain injury (Fantini et al., 2016).  
The brain receives blood via two pairs of arteries: the internal carotid arteries and the 
vertebral arteries (VA). The internal carotid artery then bifurcates into the middle cerebral 
artery (MCA) and the anterior cerebral artery (ACA), with the middle cerebral artery being the 
larger division of the ICA (Makowicz, Poniatowska, & Lusawa, 2013). The MCA provides blood 
flow to portions of the frontal lobe and the lateral surface of both the temporal and parietal 
lobes of the brain by distributing blood to the anterior circulation (Chandra, Li, Stone, Geng, 
& Ding, 2017). The vertebral arteries anastomose to form a singular basilar artery, which then 
bifurcates into the left and right posterior cerebral arteries which supply blood to the occipital 
lobe and the brain stem (posterior circulation) (Chandra et al., 2017). The posterior circulation 
is connected by the posterior communicating arteries, while the anterior communicating 
artery connects the left and right anterior cerebral arteries, which forms an arterial 
anastomotic ring called the circle of Willis (Figure 1). In human brains, the circle of Willis 
comprises the anterior cerebral arteries, anterior communicating artery, posterior cerebral 
arteries, and the posterior communicating arteries (Vrselja, Brkic, Mrdenovic, Radic, & Curic, 
2014) and due to the  anastomotic arrangement, the circle of Willis forms collateral circulation 
for the cerebral circulation (see Figure 1). There are many structural variations of the circle of 
Willis, and though the collateral circulation function stays intact, an abnormal circle of Willis 
will determine the occurrence, manifestation, and treatment of cerebrovascular disease 




Figure 1 Diagram of the arteries forming the circle of Willis (Vrselja et al., 2014).  
 
 CBF can be defined as “the blood volume that supplies the brain at a given time”, 
written in the units of ml blood / min (Fantini et al., 2016). Poiseuille’s law is a fundamental 
law in haemodynamics and states that the rate of blood flow is determined by the change in 
pressure (𝛥𝑃), vessel diameter (r) to the fourth power, and is inversely related to the length 
of the vessel (L) and the coefficient of viscosity (𝜂); 




Changes in blood pressure (BP), cardiac output, neural metabolism, arterial partial 
pressure of carbon dioxide (PaCO2), and sympathetic nerve activity all alter CBF (Ainslie & 




Figure 2  The directional effects of physiological factors involved with CBF regulation. BP, 
blood pressure; SNA, sympathetic nerve activity; PCO2, partial pressure of carbon dioxide 
(Ainslie & Duffin, 2009). 
  Poiseuille’s law is important in determining blood flow through a vascular bed. In the 
cerebral circulation, what drives blood through the vasculature of the brain is the CPP and 
inversely the CVR of the entire vascular tree (Willie et al., 2014). As mentioned earlier CPP is 
the difference between MAP and ICP (Tameem & Krovvidi, 2013). ICP tends to deviate during 
everyday activities such as breath holding (Valsalva manoeuvre) (Greenfield, Rembert, & 
Tindall, 1984), coughing and sneezing (Dunn, 2002), and postural changes, (Andresen, Hadi, 
Petersen, & Juhler, 2015; Schneider, Helden, Franke, Lanksch, & Unterberg, 1993) but also 
brain injuries can increase ICP, due to the minimal space to expand from being confined in 
the skull (Haykowsky, Eves, Warburton, & Findlay, 2003). Due to variations in MAP occurring 
more often and at a greater magnitude, this makes MAP the largest contributing factor 
affecting CPP. Small arteries and the pial arterioles contribute greatest to CVR (Kulik, Kusano, 
Aronhime, Sandler, & Winn, 2008). From Poiseuille’s law, it is evident that any changes in 
radius (i.e., vasodilation or vasoconstriction) will significantly affect CBF (Tameem & Krovvidi, 
2013).  
The brain has a poor tolerance for ischaemia (Van Lieshout et al., 2003), with tissue 
remaining viable without adequate oxygen and nutrients for only a couple of minutes (Lee, 
Grabb, Zipfel, & Choi, 2000) and if oxygen levels are not restored to adequate levels, brain 
injury and brain damage can occur (Tameem & Krovvidi, 2013). If there is an excess CBF, it 
could lead to a breakdown of the brain-blood barrier (BBB) which leads to hyperperfusion 
syndromes such as seizures, headaches, encephalopathy, and stroke (van Mook et al., 2005). 
Therefore, understanding CBF regulation will help us better understand pathologies caused 
by a compromised CBF.  
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2.2 Regulation of CBF 
2.2.1 Arterial Partial Pressure of Carbon Dioxide 
 The discovery that arterial partial pressure of carbon dioxide (PaCO2) has a significant 
effect on CBF was first made by Kety and Schmidt (1945), with more recent data indicating 
bePaCO2 is the most potent regulator of CBF (Figure 2) (Ainslie, Ashmead, Ide, Morgan, & 
Poulin, 2005; Verbree et al., 2014). Kety and Schmidt (1948) found that an elevation in PaCO2 
(hypercapnia) produces vasodilation which leads to an increase in CBF. In contrast, a low level 
(hypocapnia) leads to a reduction in CBF (Kety & Schmidt, 1946; Wasserman & Patterson, 
1961). Therefore, PaCO2 is seen to have an effect on vascular resistance by altering vessel 
diameter. How CO2 initiates changes in vascular tone is still unknown (Battisti-Charbonney, 
Fisher, & Duffin, 2011), however it is believed that carbon dioxide produces a change in H+ 
ions which activates the voltage potassium channels leading to hyperpolarisation of the 
endothelial cells, thus altering the vascular tone of the vessel (Ainslie & Duffin, 2009; 
Kitazono, Faraci, Taguchi, & Heistad, 1995; Nelson & Quayle, 1995).  
Fortune et al. (1992) demonstrated an increase in CBF by 3% when they increased 
PaCO2 by 1 mm Hg. Battisti-Charbonney et al. (2011); Ide, Eliasziw, and Poulin (2003); Skow et 
al. (2013); Willie et al. (2012) showed that for every 1 mm Hg increase in PaCO2 there was a 3 
– 6% increase in CBF, whilst for every 1 mm Hg decrease in PaCO2 there was an approximate 
1 – 3% decrease in CBF. Any changes in PaCO2 are rapidly followed by changes in CBF. Whilst 
CBF may be more sensitive to hypercapnia compared to hypocapnia, Wasserman and 
Patterson (1961) found that only a 2 mm Hg decrease in PaCO2 is required to initiate 
vasoconstriction of vessels. In contrast, a 4.5 mm Hg increase is needed to initiate 
vasodilation. Wasserman and Patterson (1961) also discovered that once the threshold of 4.5 
mm Hg increase is reached, the overall CBF pattern to prevailing hypercapnia is sigmoidal. 
Once chemoreceptor activation is sufficient to increase MAP then it also becomes a pressure-
dependent response (Battisti-Charbonney et al., 2011). Conversely, unlike hypercapnia, once 
the 2 mm Hg decrease in PaCO2 is reached, there is not a linear response to a  hypocapnia, 
but a smaller response in CBF per unit decrease in arterial carbon dioxide (Wasserman & 
Patterson, 1961).  
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2.2.2 Arterial Partial Pressure of Oxygen 
 Although carbon dioxide may be the most potent regulator of CBF, arterial partial 
pressure of oxygen (PaO2) still contributes to the regulation and can have a significant effect 
on CBF (Kety & Schmidt, 1948). Hyperventilation (arising from hypoxia) would produce 
hypocapnia and reduction in CBF, reflecting the greater influence of CO2 on CBF. However, 
isocapnic hypoxia has been seen to increase cerebral vasodilation (Ainslie & Poulin, 2004). 
Vasodilation is achieved through the process of activating the membrane of the potassium 
(K+) channels which decreases calcium (Ca2+) levels, thus producing a relaxation effect on 
vessel tone (Pearce, 1995). Hypoxia-induced increases in CBF are complex, and there are 
many contributing factors to the increase seen in CBF. For example, to observe an increase in 
CBF, PaO2 will need to be at ~45 mm Hg and oxygen (O2) saturation at ~80% (Ainslie & Poulin, 
2004; Willie et al., 2012).  
 Adenosine is a metabolite that has been seen as a mediator of hypoxic cerebral 
vasodilation (Willie et al., 2014), due to the release of adenosine with hypoxaemia (Meno, 
Ngai, & Winn, 1993). Furthermore, in vitro, it has been demonstrated that adenosine 
obstructs signals for vasoconstriction within the parenchyma (Gordon, Choi, Rungta, Ellis-
Davies, & MacVicar, 2008). Bowton et al. (1988) investigated the effects of adenosine on 
humans and found that there was a decrease in CBF as well as cerebral oxygen delivery during 
normoxia when adenosine was inhibited by the administration of aminophylline. 
Furthermore, the authors also reported that although CBF decreased during normoxia, it 
increased during hypoxaemia with aminophylline administration. This indicates that 
adenosine is associated with hypoxic cerebral vasodilation response, however, it cannot be 
the only mediator of hypoxic-induced increases in CBF. Nitric oxide (NO) is another metabolite 
that is commonly associated with L-arginine (L-LMMA) infusion on the regulation of 
cerebrovascular vessels during normoxia and hypoxia. They found that administration of L-
LMMA during normoxia did not alter CBF. However, during hypoxia CBF increased and after 
L-LMMA was administered CBF and CVR returned to baseline measures.  
2.2.3 Arterial Blood Pressure 
  Cerebral autoregulation is a homeostatic mechanism that contributes to maintaining 
constant CBF despite changes to CPP. Lassen (1959) came up with the concept of cerebral 
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autoregulation when he compiled data sets from seven different studies and calculated the 
now well-known autoregulatory curve (Figure 3). The classic autoregulatory curve showed 
that CA was extremely effective, with CBF staying at a constant level when MAP was between 
60 and 150 mm Hg.  CA works by altering CVR in response to the change in CPP (Whittaker et 
al., 2017; Willie et al., 2014). CA acts as a negative feedback loop, reacting to the changes in 
the MAP to stabilise CBF (Tzeng & Ainslie, 2014). A decrease in MAP would elicit vasodilation 
of the cerebral vessel thus increasing CBF. Conversely, hypertension would induce 
vasoconstriction, increase CVR and decrease CBF (Fantini et al., 2016).   
 One of the first studies demonstrating the influence of blood pressure on 
cerebrovascular arteries was completed by Fog (1939a, 1939b). He found that a significant 
decrease in blood pressure caused the pial arteries of the brain to dilate within seconds of 
the decrease. This inferred that a decrease in blood pressure caused dilation of cerebral 
arteries and, therefore, increased CBF. Furthermore, Kontos et al. (1978) reported that during 
changes in CPP the smaller arteries and arterioles of the brain dilated within seconds, thus 
reflecting that changing CVR of smaller cerebral vessels contributes to defending against 
arbitrary changes to CPP (Aaslid, Lindegaard, Sorteberg, & Nornes, 1989). Static cerebral 
autoregulation (sCA) and dynamic cerebral autoregulation (dCA) are the same mechanism 
that responds to the changes in MAP occurring in the cerebral circulation, with the only 
difference being the time frame in which they respond (Tan & Taylor, 2014; Zhang, 
Zuckerman, Giller, & Levine, 1998). sCA is engaged when change in MAP is gradual (minutes 
to hours) and/or is sustained over a period of time and buffers lower frequencies (<0.5 Hz) 
MAP changes, whilst dCA regulates rapid (seconds) changes to MAP in the higher frequency 
range (>0.5 Hz).  
 Although the exact mechanism/s are not clear, it has been suggested that CA 
comprises of three physiological mechanisms that contribute to maintaining stable CBF, the 
myogenic, metabolic, and neurogenic mechanisms (Tzeng & Ainslie, 2014; Willie et al., 2014). 
The myogenic mechanism is how vascular smooth muscles respond to a change in transmural 
pressure (Ibrahim, McGee, Graham, McGrath, & Dominiczak, 2006). Changes in transmural 
pressure induce a change in arterial diameter through constriction or dilation of the smooth 
muscles (Osol & Halpern, 1985). Metabolic mechanism refers to the changes in the 
concentrations in metabolites that influence changes in the vasoactive properties of blood 
26 
 
vessels. These metabolites can change the permeability of the vessel, which can cause 
contraction of the smooth muscles, thus changing the vessel properties (Panerai, 2008). The 
neurogenic mechanism of CA is characterised by the neurons secreting neurotransmitters 
with the ability to decrease and increase small to moderate vessel diameters to regulate CBF 
(Rivera-Lara et al., 2017). Furthermore, the neurogenic mechanism is also referred to as 
neurovascular coupling. As discussed in Section 2.10, neurovascular coupling is the increase 
in blood flow to local or global brain regions in response to increased neuronal activity 
(Belanger, Allaman, & Magistretti, 2011). The mechanisms that contribute to CA are all 
chemically regulated, which infers that a set amount of time is needed to induce the necessary 
changes in CVR in response to changes in the MAP (Fantini et al., 2016). dCA processes occur 
rapidly and therefore, is the contribution of the myogenic response (Bevan & Hwa, 1985). dCA 
is regulated by the stretch-activated ion channels (Peterson, Wang, & Britz, 2011), where the 
stretch of the vessel wall is caused by changes in blood pressure (Bevan & Hwa, 1985). 
Voltage-gated Ca2+ channels are sensitive to mechanical stimuli (Hill, Zou, Potocnik, 
Meininger, & Davis, 2001; Schubert & Brayden, 2005), therefore, intracellular Ca2+ 
concentrations can be altered due to stretch stimuli (Davis & Hill, 1999; Hill et al., 2001; 
Schubert & Mulvany, 1999). Tzeng, Chan, Willie, and Ainslie (2011) reported that blocking 
Ca2+ channels of the brain cause large cerebral vessels to dilate, thus decreasing middle 
cerebral artery blood velocity (MCAv) and increasing pressure-driven blood flow, highlighting 
the importance of Ca2+ in dynamic autoregulation.  
2.2.4 Dynamic Cerebral Autoregulation  
 Dynamic cerebral autoregulation quantifies the changes in middle MCAv in response 
to abrupt alterations in CVR due to rapid changes in ABP (Aaslid et al., 1989). Technological 
advances such as the development of  transcranial Doppler (TCD) ultrasonography and the 
finger photoplethysmography (Finapres) enabled the examination of the dynamics of the 
pressure-flow relationship of CBF by allowing beat-to-beat observations of CA responses to 
BP of different magnitude and duration (van Beek, Claassen, Rikkert, & Jansen, 2008). Aaslid 
et al. (1989) conducted the first experiment looking at dCA using the TCD. They induced a 
sudden change in ABP using a thigh-cuff deflation method in which they inflated the thigh 
cuff 20 mm Hg above the participant’s systolic pressure for 2 minutes, then deflated the thigh 
cuff causing instantaneous hypotension. The authors found that dynamic cerebral 
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autoregulatory capacity is more efficient at compensating transient hypertension rather than 
transient hypotension. This phenomenon is referred to as hysteresis (Brassard, Ferland-Dutil, 
et al., 2017). Tzeng, Lucas, Atkinson, Willie, and Ainslie (2010) found there is a compensatory 
relationship between baroreflex and dCA. If an individual possesses greater dCA response, 
then they have lesser baroreflex sensitivity and vice versa. This indicates there is an 
interaction between dCA and baroreflex sensitivity to regulate any abrupt changes in blood 
pressure. 
2.2.4.1 Effects of PaCO2 on Cerebral Autoregulation 
 Carbon dioxide is the most potent regulator of CBF (Ainslie et al., 2005), however the 
effects of PaCO2 on CA can vary. Aaslid et al. (1989) and Czosnyka, Harris, Pickard, and 
Piechnik (1993) reported that dCA was compromised during hypercapnia. The plateau seen 
in the autoregulation curve shortens and is shifted to the right, whilst the upper limit of the 
curve is shifted left, thus decreasing the range and efficiency of the autoregulatory 
mechanism (Meng & Gelb, 2015). The brain can become pressure-passive when the 
hypercapnic stimulus produces chemoreceptor-induced increases in MAP (Battisti-
Charbonney et al., 2011). During severe hypercapnia, the cerebral vessels are fully dilated, 
which results in the plateau in the autoregulatory mechanism to be lost, thus leading to a 
linear relationship between pressure and flow (Meng & Gelb, 2015).  McCulloch, Visco, and 
Lam (2000) showed that in patients under general anaesthesia, graded hypercapnia impaired 
sCA.  Furthermore, McCulloch et al. (2000) reported that to significantly impair CA during 
sevoflurane anaesthesia, , the PaCO2 threshold averaged 56 mm Hg, whilst during propofol 
anaesthesia the PaCO2 threshold averaged 61 mm Hg. Hypercapnic impairments in sCA seen 
in humans under anaesthesia are also seen in conscious humans. Perry et al. (2014) saw that 
in hypercapnic conditions (+5% CO2), during a steady-state increase in MAP (+ 40 mm Hg), 
sCA was impaired with increases in MAP translated into the cerebral circulation.  
 Conversely, hypocapnia is reported to have a restorative effect on dCA (Aaslid et al., 
1989) and sCA during isoflurane anaesthesia (McCulloch, Boesel, & Lam, 2005). Meng and 
Gelb (2015) illustrated a widening of the autoregulatory plateau and the upper limit of the 
CA. Furthermore, the authors reported that any changes in the lower limits of the 
autoregulatory curve were insignificant. The downward shift seen by Meng and Gelb (2015) 
could be a concern as lower CBF can lead to hypoperfusion, and therefore ischaemia and 
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tissue damage. The vasomotor tone of cerebral vessels is the main factor regulating CA (Aaslid 
et al., 1989), with the dilatory effect of PaCO2 contributing to the impairment of CA 
(McCulloch et al., 2000). dCA has been seen to be impaired by hypercapnia and restored by 
hypocapnia (Aaslid et al., 1989); however, more studies are needed to look at these effects 
on conscious subjects.  
2.2.4.2 Effects of PaO2 on Cerebral Autoregulation 
 The arterial partial pressure of oxygen may not have a significant effect on the 
regulation of CBF compared to carbon dioxide; however, hypoxia does influence the 
regulation of CA and therefore cerebral homeostasis (Ogoh et al., 2014; Ogoh et al., 2013). 
Ogoh et al. (2014); Ogoh et al (2013) reported that during hypoxia, cerebral CO2 reactivity is 
weakened and therefore cerebral vasoconstriction is restricted, which may aid in oxygen 
delivery. Moreover, the authors found that the impaired dCA seen in hypercapnia and 
normoxia, was less during concurrent acute hypoxia, indicating that the effects of PaCO2 may 
be weakened during hypoxia to aid in regulation of CBF and O2 homeostasis. However, the 
effects of hypoxia are often confused due to the acute ventilatory response (hyperventilation) 
that occurs, which induces hypocapnia; thus, the hypoxic effect seen may be in fact caused 
by the hypocapnic mechanism.  
As mentioned above, hypocapnia improves dCA (Aaslid et al., 1989). Ogoh, Nakahara, 
Ainslie, and Miyamoto (2010) investigated the effects of hypoxia on dCA during isocapnic 
conditions. The authors reported that dCA was impaired during isocapnic hypoxia, however, 
they saw an improvement in dCA during mild hypocapnia. This highlights the dominance of 
carbon dioxide during regulation of dCA. Furthermore, Querido et al. (2013) investigated the 
effects of poikilocapnic and isocapnic hypoxia on dCA during both hypotensive and 
hypertensive changes to ABP. The authors found that the efficiency of dCA remained during 
poikilocapnic hypoxia due to the poikilocapnic induced hypocapnia via hyperventilation, 
which provided the dCA with a protective mechanism. However, during isocapnic hypoxia 
Querido et al. (2013) reported an impaired dCA, caused by the vasodilatory effects of hypoxia 
which agrees with Ogoh et al. (2010). Other studies (Jansen, Krins, Basnyat, Odoom, & Ince, 
2007; Nishimura, Iwasaki, Ogawa, & Aoki, 2010; Subudhi, Panerai, & Roach, 2009, 2010) have 
also reported no changes in CBF during poikilocapnic hypoxia, which indicates that PCO2 is 
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the superior chemical moderator of CBF than PO2, which explains why hyperventilation 
offsets the effects of isocapnic hypoxia.  
Impairments seen in dCA due to hypoxia can be alleviated by hyperoxia (Ainslie et al., 
2008; Jansen et al., 2007; Nishimura, Iwasaki, Ogawa, & Shibata, 2007; Subudhi et al., 2010). 
Hyperoxia does not directly improve dCA (Ogoh et al., 2010), but hyperoxia decreases CBF by 
increasing CVR (Subudhi et al., 2010) and produces hypocapnia through the ventilatory 
response (Becker, Polo, McNamara, Berthon-Jones, & Sullivan, 1996). Aaslid et al. (1989) 
found that the effects that improved or impaired dCA induced by PaO2 are comparable to the 
effects produced by PaCO2, due to the influence they have over vascular tone. For example, 
hypocapnia and hyperoxia induce vasoconstriction of the cerebral vessels which improve CA, 
whilst hypercapnia and hypoxia induce vasodilation which impairs CA.  
2.2.5 Static Cerebral Autoregulation 
 The static cerebral autoregulation curve proposed by Lassen (1959) has been the 
accepted model for CA for years, and the findings proved to be monumental for the time. 
However, the CA curve was generated from a combination of data sets from seven different 
studies, in which there were a total of 11 diverse participant cohorts. Thus, the CA curve was 
a representation of inter-subject values of individuals with different health conditions, instead 
of being a representation of MAP-CBF relationship in a group with the same or similar health 
status. A reanalysis of the data from Lassen’s study was done by Heistad and Kontos (1983), 
but they did not include all the data, excluding the clinical cohorts to attain a more accurate 
result. The results from the reanalysis demonstrated that CBF decreased by 2% to 7% for every 
10 mm Hg drop in the MAP and increased 7% per rise of 10 mm Hg of the MAP. Lucas et al. 
(2010) also reinvestigated the CA curve by investigating the effects of intravenous infusion of 
sodium nitroprusside and phenylephrine to elicit changes in MAP. The authors found that for 
every 1 mm Hg change in MAP a 0.8% change in MCAv was apparent, indicative of a more 
pressure-passive MAP-CBF relationship. Furthermore, Tan (2012) reported that the 
autoregulatory range might only be 5 mm Hg either side of baseline measures of blood 
pressure (Figure 3), which is much narrower than the range suggested by Lassen (1959). 
Zhang, Behbehani, and Levine (2009) conducted a study looking at the effects of steady state 
increases in ABP on MCAv and found that an increase in blood pressure by ~37% (~30 mm Hg) 
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above baseline increased MCAv by ~11%. Thus, contrasting the results by Lassen (1959) 
claiming that CBF will only increase when MAP is above 150 mm Hg.  
  
 
Figure 3 Lassen (1959) classic static cerebral autoregulation curve (left), Tan (2012) limited 
plateau cerebral autoregulation curve (right) demonstrating the inefficiency of CA. Figure 
from Tzeng and Ainslie (2014).  
2.2.6 Measuring cerebral autoregulation  
Activities such as standing up (Sorond, Serrador, Jones, Shaffer, & Lipsitz, 2009; 
Thomas et al., 2009), the Valsalva manoeuvre (Aaslid et al., 1989; Perry, Cotter, Mejuto, 
Mundel, & Lucas, 2014; Pott, van Lieshout, Ide, Madsen, & Secher, 2000; Tiecks et al., 1995), 
body weight squat-stand manoeuvre (Claassen et al., 2009), resistance exercise (Edwards, 
Martin, & Hughson, 2002; Perry, Schlader, et al., 2014; Romero & Cooke, 2007), and rowing 
(Pott et al., 1997) inflict a significant ABP oscillations that challenge dCA and are used 
experimentally to assess dCA effectiveness. The methods used to assess CA are ambiguous as 
there is no gold standard (Tzeng & Ainslie, 2014; Tzeng, MacRae, Ainslie, & Chan, 2014). One 
method of assessing CA is  to assess the linear relationship  between ABP and CBF at rest 
(Zhang et al., 1998), as normal respiration and cyclic change sin autonomic tone generate 
spontaneous fluctuations in MAP. Conversely, ABP can be manipulated experimentally, so 
called driven or forced change sin MAP. Such forced oscillations can be elicited by the 
manoeuvres described above, with two common modes being repeated squat stands and the 
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Valsalva manoeuvre,  (Claassen, Levine, & Zhang, 2009; Tan, 2012) to challenge the regulatory 
mechanisms. Hamner et al. (2019) examined CA at very low frequencies (<0.03 Hz) and low 
frequencies (0.03 – 0.10 Hz) using oscillatory lower body negative pressure (OLBNP) and 
determined that CA is most effective at buffering changes in ABP at frequencies below 0.03 
Hz. Whilst some argue that as the brain is counteracting spontaneous fluctuations in MAP 
more frequently, assessing dCA at rest provides a more accurate representation of 
cerebrovascular function (Tzeng & Panerai, 2018). However, the counterargument is that 
everyday life activities cause changes in ABP far greater than those experienced during rest, 
therefore it is important to examine how CBP responds to these insults (Simpson & Claassen, 
2018). There is an obvious decrease in CA variability observed when CA is challenged by 
increasing ABP (Birch, Neil-Dwyer, & Murrills, 2001; Claassen et al., 2009). Eliciting changes to 
ABP allows confirmation that there is a correlation between ABP and CBF, which is a 
prerequisite for assessing CA. Irrespective of how the change in in the input (MAP) is 
produced, dCA can be assessed in several ways and three methods are described below 
2.2.6.1 Autoregulatory Index 
 Dynamic cerebral autoregulation can also be assessed using Tiecks et al. (1995) 
autoregulatory index (AI). Tiecks’s AI evaluated dCA by measuring the relative change in CBFv 
(output) in response to rapid (dynamic) changes in BP (input). The CBFv response generated 
is compared with 10 theoretical curves that was created using the changes in BP and exact 
combinations of its parameters to evaluate autoregulation (Tiecks et al., 1995). The 
effectiveness of dCA can be quantified by comparing the actual CBFv response with one of 
the 10 curves generated. The autoregulatory index that ranges from 0 (which indicates an 
absence of autoregulation) to 9 (which indicates the best autoregulation). AI is one of the 
straightforward methods to measure dCA and can be implemented during the Valsalva 
manoeuvre (VM) (Tiecks et al., 1995). As mentioned in Section 2.5 below, the VM is an 
effective technique which induces both increases and decreases in BP. The AI values for the 




2.2.6.2 Rate of Regulation 
 Rate of regulation (RoR) is another method to examine dCA and uses the equation: 
RoR = (∆𝐶𝑉𝑅/∆𝑡)/∆𝐴𝐵𝑃 (Aaslid et al., 1989). This method has been used to determine the 
efficiency of dCA following thigh cuff occlusion and more recently by Labrecque et al. (2019) 
to examine dCA during the sit-to-stand manoeuvre. A critical aspect of the RoR equation is 
the time in which the changes to CVR occur without the arterial baroreflex regulation (Aaslid 
et al., 1989). Aaslid et al. (1989) found that the time in which CVR is strictly influenced by dCA 
to be approximately 1 – 3.5s. The linear regression slope demonstrates the rate of change in 
CVR, which is dependent on ABP. Theoretically, CBF would be maintained if CVR and ABP were 
the same, however, that is unlikely, therefore ABP largely influences the RoR (Aaslid et al., 
1989).  The lower the RoR the more efficient the dCA response to changes in ABP.  
2.2.6.3 Transfer Function Analysis 
Transfer function analysis (TFA) is a frequency analysis that describes the linear relationship 
between the input signal (blood pressure) and the output signal (CBF or a proxy e.g. MCAv), 
with dCA being the regulator (Tzeng & Ainslie, 2014). Resultant metrics include Gain 
(magnitude), phase shift (timing), and coherence (dependence) are three factors in which dCA 
describes the transfer function between fluctuations in BP and MCAv. The gain calculates how 
well CA reduces the transfer of input (BP) to output (MCAv). The dampening effect (gain) 
between BP and MCAv is observed in the size of fluctuations in BP. An efficient CA is 
represented by a low gain, while conversely, a high gain illustrates an ineffective CA process. 
Phase shift describes the movement of ‘in phase’ waveforms comparative to a different 
waveform with the same period. The phase shift is used to identify the time lag of the 
autoregulatory response. The differences are described in degrees or radians. An efficient CA 
is seen as a ‘phase lead’ where the phase shift between input and output is a positive number. 
Conversely, if the number is closer to zero, then CA can be described as inefficient. The linear 
relationship between the input and output signals is referred to as the coherence. If the 
frequency of both input and output are almost in sync at a particular frequency, then this 
would indicate that there is a linear relationship. No relationship between input and output 
signals can be described when there is a coherence of zero. When quantifying gain and phase 
shift, the cut-off of coherence >0.5 is used (Zhang et al., 1998).   
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2.2.7 Neurovascular Coupling 
 Neurovascular coupling (NVC) involves a matching increase in CBF to local or global 
regions of the brain to sustain neuronal function, due to an increase in neuronal activity in 
that area (Attwell et al., 2010; Belanger et al., 2011). During NVC, arterioles in the area of 
increased neuronal activity dilate within seconds, to sufficiently supply active neurons with 
oxygen and substrates (Carmignoto & Gomez-Gonzalo, 2010). Astrocytes play a critical role in 
the mediation of the coupling of neuronal function and vascular response (Zonta & 
Carmignoto, 2002), via the glutamatergic-mediated pathways. One of these glutamate-
mediated pathways is Ca2+ dependent. An increase in intracellular Ca2+ concentration in 
astrocytes initiates the activation of voltage-gated Ca2+ channels, stimulating vasodilation 
(Filosa & Blanco, 2007).  Astrocyte end feet are in close proximity to the vessel walls, which 
allows for intracellular Ca2+ signalling to the vessel walls, thus triggering a vascular response 
(Chow et al., 2020; Simard, Arcuino, Takano, Liu, & Nedergaard, 2003).  Rosengarten, Spiller, 
Aldinger, and Kaps (2003) investigated the effects of hypercapnia and normocapnia on 
neurovascular coupling using visual stimuli. The authors found that hypercapnia impaired dCA 
by slowing down the initial component. However, hypercapnia enhanced the NVC to the area 
of the brain being stimulated, thus increasing CBF in that area. This indicates that the initial 
slow blood flow velocity at the start of dCA aided in distributing blood flow to the activated 
areas. Further information on neurovascular coupling and the influences it has on CBF can be 
found in reviews such as Attwell et al. (2010); Filosa and Blanco (2007); Iadecola and 
Nedergaard (2007).  
2.2.8 Autonomic Nervous System (ANS) 
 Cerebral vessels are greatly innervated by adrenergic and cholinergic fibres 
(Edvinsson, 1975; Gulbenkian, Uddman, & Edvinsson, 2001), however, the role of the 
autonomic nervous system in the regulation of cerebral circulation remains contentious 
(Brassard, Tymko, & Ainslie, 2017; Gulbenkian et al., 2001; Heistad & Marcus, 1978; 
Strandgaard & Sigurdsson, 2008). Due to the difficulties of methods, there have been limited 
studies examining the role of the autonomic nervous system in the regulation of CA and the 
results are inconsistent (Zhang et al., 2002). Only a handful of studies managed to examine 
the sympathetic nervous systems (SNS) contribution to CA in humans via pharmacological 
blockade. Zhang et al. (2002) induced a ganglionic autonomic blockade by administering 
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trimethaphan to examine the cross-spectral relationship between ABP and the fluctuations in 
CBF via OLBNP.  The authors found that ganglionic autonomic blockade altered dCA, as ABP 
and CBF both decreased, whilst TFA gain was doubled and phase was decreased at low 
frequencies. Thus, indicating that CA had been reduced. However, the ganglionic autonomic 
blockade stopped both the sympathetic and parasympathetic nervous control, therefore the 
effect on dCA could have been from either nervous system or both (Tan & Taylor, 2014). 
Hamner, Tan, Lee, Cohen, and Taylor (2010) conducted a similar study using OLBNP to 
examine the cross-spectral relationship between ABP and low-frequency fluctuations in CBF. 
The authors induced an α-adrenergic blockade using phentolamine. Hamner et al. (2010) 
results were similar to Zhang et al. (2002), with the sympathetic blockade increased gain and 
coherence and decreased phase, thus highlighting that there is sympathetic nervous influence 
on CA.  This notion is further supported by a study by Ogoh, Brothers, Eubank, and Raven 
(2008) and Zhang, Crandall, and Levine (2004). Ogoh et al. (2008) showed that α1-
adrenoreceptor block with prazosin weakens CBF recovery from transient hypotension. Zhang 
et al. (2004) found that after autonomic ganglion blockade with trimethaphan, dCA was 
unable to prevent the significant phase IV overshoot in MCAv in the VM (see Section 2.14 for 
descriptions of VM phases). Although MAP rapidly increased from phase III, no Phase IV BP 
overshoot was observed. Despite the reduced phase IV response, MCAv increased by 55%, 
indicative of a loss of vasoconstrictor ability, indicative that the sympathetic nervous system 
restrains MCAv during rising CPP.  
  Data available for the effects of cholinergic control in CA was scarce in humans, 
however, cholinergic nerves are found distributed throughout intracranial vessels (Hamel, 
2004; Heistad, Marcus, Said, & Gross, 1980; Sato, Sato, & Uchida, 2001). There has only been 
one study examining the effects of the parasympathetic nervous control on cerebrovascular 
control. Hamner, Tan, Tzeng, and Taylor (2012) studied the effect of cholinergic blockade 
using glycopyrrolate on the pressure-flow relationship during OLBNP at six different 
frequencies (0.03 – 0.08 Hz). The authors reported that systemic cholinergic blockade 
impaired CA, as an increase in transfer function coherence was shown between MAP and CBF. 
This demonstrates that the parasympathetic nervous control has an active and special role in 
CA. Moreover, Hamner and Tan (2014) reported that the cholinergic nervous control 
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contributes to a small but significant role in CA, especially in the gain and upper pressure limit 
in the active regions of CA.  
2.3 Cerebral blood flow regulation differences: Males versus Females 
 Regulation of CBF differs between males and females due to the different sex 
hormones circulating in the blood (Krause et al., 2006; Robison et al., 2019). Sex hormones 
are produced in the gonads but can be produced in extragonadal sites such as vasculature 
and the brain (Simpson et al., 2000). This is important, especially for menopausal women 
(Simpson et al., 2000). The three main cholesterol-derived sex steroid hormones are 
androgens (testosterone (T) and dihydrotestosterone (DHT)), oestrogens (estrodiol (E2), 
estrone, estriol), and progestogens (progesterone (P4)) (Pelligrino & Galea, 2001; Robison et 
al., 2019). Oestrogen is often perceived as the female sex hormone, while androgens are seen 
as purely male sex hormones. However, females and males have both oestrogens and 
androgens, albeit at varying concentrations (Robison et al., 2019).   
 The different concentrations of androgens and oestrogens in females and males 
influence their cerebral vasculature reactivity and therefore CBF (Krause et al., 2006). Due to 
having higher oestrogen concentrations, females are seen to have greater CBF throughout 
their life compared to their male counterparts. This is because oestrogen increases cerebral 
vasculature production and/or sensitivity to vasodilatory factors (Chrissobolis & Sobey, 2004; 
Geary et al., 1998; Geary, Krause, & Duckles, 2000a; Ospina, Duckles, & Krause, 2003; Ospina, 
Krause, & Duckles, 2002; Skarsgard, van Breemen, & Laher, 1997) and counteract the effects 
of vasoconstrictive mechanisms (Chrissobolis, Budzyn, Marley, & Sobey, 2004). Oestrogen has 
been reported to increase nitric oxide production by activating multiple mechanisms that 
increase endothelial NO synthase (eNOS) (Orshal & Khalil, 2004), such as increasing oestrogen 
receptor (α) density, which stimulates eNOS gene expression (Mendelsohn & Karas, 1999). 
This mechanism is referred to as a genomic mechanism because it takes hours to days to 
initiate vasodilation. However, oestrogen also stimulates non-genomic mechanisms such as 
increasing the activation of the oestrogen receptor pathway. This pathway activates 
phosphoinositide-3 kinases-Akt signalling to phosphorylate eNOS at serine-1177/1179, which 
increases the enzyme activity of eNOS and makes the enzyme more sensitive to Ca2+ 
stimulation (Ho & Liao, 2002; Stirone, Boroujerdi, Duckles, & Krause, 2005). Figure 4 below 
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shows both the non-genomic and genomic mechanisms in which oestrogen increases cerebral 
vasodilation and thus increases CBF in females.  
 
Figure 4 Summary of supposed mechanisms facilitating genomic and non-genomic effects of 
oestrogen on vasodilating function in cerebral vessels from Krause et al. (2006). ER, oestrogen 
receptors; Ca2+, calcium; PI-3K, phosphoinositide-3 kinase Akt; p-eNOS, serine-1177/ 1179-
phosphorylated endothelial NO synthase (eNOS); CAV-1, caveolin-1; VSM, vascular smooth 
muscle; COX, cyclooxygenase, PGI2, prostacyclin; EDHF, endothelial derived hyperpolarising 
factor. 
 Conversely, androgens such as testosterone have the opposite effect to that of 
oestrogen. Testosterone is seen to induce vasoconstriction in the cerebral vessels as a 
response to transmural pressure (Geary et al., 1998). In vivo studies have investigated the 
effects of constant exposure to androgens in male rats (Geary, Krause, & Duckles, 2000b; 
Gonzales, Krause, & Duckles, 2004). The authors found that androgens vasoconstricted the 
MCA through the endothelial BKCa–dependent/NO-independent mechanism. In male rats a 
gonadectomy was seen to elicit vasodilation, however; chronic exposure to testosterone in 
male rats with a gonadectomy was seen to decrease vasodilator endothelial-derived 
hyperpolarising factor (EDHF) expression in conjunction with increasing the potent 
vasoconstrictor thromboxane expression in the MCA (Gonzales, Ghaffari, Duckles, & Krause, 
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2005; Gonzales et al., 2004). Vascular relaxation has been reported in acute androgen 
treatments; however, it has not yet been tested on cerebral vessels. Therefore, the effects of 
androgen hormones on cerebral vessels may be dose-dependent (Robison et al., 2019). 
2.4 Sex Hormone levels in Women  
 Women experience different sex hormone concentrations reflecting which stage of 
their life they are currently in, what phase of the menstrual cycle they are in and if they use 
contraception. There is an increase in oestrogen concentrations during pregnancy (Brackley, 
Ramsay, Pipkin, & Rubin, 1998), whilst during menopause there is a substantial decrease in 
oestrogen concentrations (Su & Freeman, 2009). Oestrogen (17β-estradiol) and progesterone 
concentrations also fluctuate during the menstrual cycle (Brackley, Ramsay, Broughton 
Pipkin, & Rubin, 1999; Diomedi et al., 2001; Krejza et al., 2004; Krejza et al., 2003). These 
undulating hormone concentrations have been reported to have different effects on the 
cerebral circulation of women. As seen in Figure 5, during the late follicular phase, when 
oestrogen concentrations are highest and progesterone concentrations remain steady, 
cerebrovascular reactivity to CO2 increases (Diomedi et al., 2001). 17β-estradiol 
concentration increases in the late follicular phase and reaches a peak on day ~14 (Krejza et 
al., 2003). During this time there is also a decrease in resistance in the internal carotid arteries, 
thus leading to an increase  CBF  (Krejza, Mariak, Huba, Wolczynski, & Lewko, 2001).  
Alternatively, during the mid-luteal phase, both oestrogen and progesterone concentrations 
are high, however there is an increase in CVR conjointly with the increase in progesterone 
(Krejza et al., 2004). Furthermore, studies have shown that progesterone has the ability to 
counteract the vasodilatory effects of oestrogen, through competitive blockage in the 
vascular tree of oestrogen receptors by progesterone (Miller & Vanhoutte, 1991; Willekes, 
Hoogland, Keizer, Hoeks, & Reneman, 1999). An increase in progesterone also initiates 
hypocapnia via an increase in ventilation, producing the observed increase in CVR (Brackley 









Figure 6 Left: Resistance Index (RI) in Internal (ICA) and external (ECA) and common (CCA) 
carotid arteries and 17β-estradiol and progesterone concentrations during the menstrual 
cycle (Krejza et al., 2004). Right: 17β-estradiol and progesterone concentrations and end-




 As described in the previous paragraph, the changing hormone concentrations 
throughout the menstrual cycle can alter the haemodynamics of cerebral vessels and 
therefore can influence CBF (Krause et al., 2006). However, some studies have reported an 
increase in internal carotid artery blood velocity as a consequence of increased endogenous 
(Krejza et al., 2004) and exogenous oestrogen (Ohkura et al., 1995), while one has reported 
no change in CBF (Bain, Lees, Lumsden, & Walters, 2005). Furthermore, during the luteal 
phase, progesterone has a more dominant effect, producing vasoconstriction in the ICA and 
reducing mean ICA velocity (Krejza et al., 2004). The authors found that from base measures 
(pulsatility index (PI) measures from day 3 and day 6), late follicular day 13 and day 14 showed 
a decrease in resistance and increase in ICA blood velocity which is greater than day 17 when 
progesterone and oestrogen concentrations are both high. The oscillating changes in 
hormones during the menstrual cycle could contribute to women experiencing greater 
orthostatic hypotension compared to men (Ali et al., 2000; Cheng, Vyas, Hymen, & Perlmuter, 
2011). It has been reported that during the early follicular phase, there is a higher incidence 
of light-headedness (Muppa et al., 2013; Peggs et al., 2012), which could be caused by 
increased vasodilation of cerebral vessels and the inability to vasoconstrict peripherally 
promptly during orthostasis. 
2.5 Valsalva Manoeuvre  
    An essential aspect of the assessment of dCA is to look at the response of cerebral 
blood flow to changes in blood pressure. There are numerous methods to cause oscillations 
or sudden increases and decreases in blood pressure. For the purposes of this thesis the VM 
was the intervention of choice to challenge cerebrovascular regulation.  
The VM is a simple but effective technique to induce characteristic changes in blood 
pressure and CBFv (Tiecks et al., 1995). There are four distinct phases of the VM that reflects 
the changes in ABP, which can be seen in Figure 9 in Section 3.10. Phase I is defined as the 
initial increase in blood pressure that occurs due to the increase in intrathoracic and intra-
abdominal pressure, which occurs at the onset of straining (breath hold). Phase IIa is 
characterised by the first decrease in blood pressure seen in Figure 9. The decrease in blood 
pressure is because the reduction in venous return and decreased stroke volume. The 
decrease in ABP activates the baroreflex which initiates vasoconstriction and increases HR 
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(phase IIb) (Remmen, Aengevaeren, Verheugt, & Jansen, 2005). Once the strain is alleviated, 
there is a rapid decrease in MAP (phase III) (Tiecks et al., 1995), and the overshoot seen in 
MAP is phase IV of the VM, as cardiac output has been restored and being ejected into the 
constricted vasculature. Williams (1981) observed that an increase in intrathoracic pressure 
could translate into an increase in intracranial pressure, which consequently can decrease 
CPP more than what is reflected by BP. Pott, van Lieshout, Ide, Madsen, and Secher (2000) 
observed a decrease in PaCO2 during the standing VM. This indicates that during a 15s VM, 
the decrease in PaCO2 contributes to the 10 – 15% decrease in MCAv observed. Moreover, 
the VM was being performed standing up, indicating that orthostatic factors such as stroke 
volume and cardiac output contributed to the decrease in MCAv. 
2.6 Previous Literature the effects of hormone concentration on cerebrovascular 
regulation 
 Previous studies by Abidi et al. (2017) and Favre and Serrador (2019) both investigated 
the sex differences in CA across the menstrual cycle. Abidi et al. (2017) investigated women 
on the oral contraceptive pill (n = 14) and women who were not on the contraceptive (n = 12) 
during the low hormone days (days 2 – 5) and high hormone days (day 18 – 24) of the 
menstrual cycle. Low hormone was defined as early follicular, when circulating oestrogen and 
progesterone was low and high hormone was identified as mid-luteal, when circulating 
oestrogen and progesterone was high (also see Figure 5). To challenge CA, the participants 
partook in the VM and a supine-sit-stand protocol. The authors found that women have 
superior CA when compared to their male counterparts. Abidi et al. (2017) also reported that 
during the high hormone phase of the menstrual cycle, there was a greater tendency towards 
vasoconstriction during the VM and the supine-sit-stand protocol, however there were no 
significant differences in CA between the different menstrual cycle phases. Abidi et al. (2017) 
compared low oestrogen and progesterone concentrations to high oestrogen and 
progesterone concentrations, which made it difficult to distinguish which hormone was 
eliciting the effect seen in cerebrovascular response. 
 Favre and Serrador (2019) examined the difference in CA between males and females, 
but, also the difference in CA across three different stages of the menstrual cycle; early 
follicular (~day 3), late follicular (~day 13), and the mid-luteal (~day 23). The female 
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participants of this study were not on any form of contraception. The sit-to-stand manoeuvre 
and repeated squat-to-stand manoeuvre were used to challenge CA. Similar to Abidi et al. 
(2017), Favre and Serrador (2019) did not find any significant differences in cerebral 
autoregulation across the menstrual cycle in women. Furthermore, young women 
demonstrated improved CA than men. The authors measured MCAv and anterior cerebral 
artery blood velocity, which both branch off the ICA. Changes seen, or lack of changes seen in 
CA could be due to the fact that the vessels of interest both stem from the same artery. The 
study did not look at the posterior cerebral artery blood velocity (PCAv), which stems from 
the VA. The VA is smaller than the ICA, therefore any changes in CBF as a result in changing 
ABP could be more evident due to the smaller vessels. Moreover, Favre and Serrador (2019) 
only challenged dCA using the sit-to-stand and repeated squat-to-stand manoeuvre. Favre 
and Serrador (2019) were more specific with the menstrual cycle, investigating the early 
follicular, late follicular and the mid-luteal phase, which permitted a more in-depth 
examination of both oestrogen and progesterone. However, the authors reported that the 
salivary estradiol concentrations for 39% of the participants were lower than what was 
expected in late follicular, suggesting that oestrogen levels were low when it was expected to 
be highest. Furthermore, individual cycles vary, and direct plasma hormone measurement is 
the most robust method to adequately confirm a participant’s position with the menstrual 
cycle. Furthermore, there are some factors that can contaminate salivary hormone levels. 
Drinks such as coffee can interfere with the test and cause a transient shift in hormone levels 
(Lipson & Ellison, 1989). Chewing gum can increase salivary production, however, it could 
cause bleeding gum, which would contaminate the sample with blood and blood can cause 
significant changes in hormone levels (Dabbs Jr, 1991). Over the years salivary samples have 
become more prominent in identifying hormone levels, however, there are many factors that 
are overlooked which can produce unreliable results. The unreliable results of salivary 
sampling suggest that direct measurement of plasma hormone concentrations is a more 
suitable method to measure oestrogen concentrations.  
2.7 Summary 
 This literature review discussed the cerebral circulation and the abundant factors that 
contribute to its regulation to ensure optimal brain function. There are many factors that 
contribute to the regulation of CBF, however, the interactions between these factors and how 
43 
 
much they contribute to the overall CBF regulation is less understood. Furthermore, the role 
of sex steroid hormones on cerebral circulation has not been examined extensively. It is 
known that oestrogen can alter reactivity of the cerebral vasculature via vasodilation and that 
progesterone initiates a vasoconstrictive response, and that these different cerebral reactivity 
responses can translate to CBF. Moreover, in women, hormone concentrations change 
throughout their life, such as during the menstrual cycle, pregnancy, and menopause. 
Changes in hormone concentrations during the menstrual cycle can have adverse effects, 
especially when women are more prone to orthostatic hypotension than men. Furthermore, 
women’s hormones can be manipulated by oral contraceptives, therefore the full effect of 
the hormones especially oestrogen, has not been fully studied and understood. Therefore, 
the main objective of this Masters thesis was to examine effect of oestrogen on 
cerebrovascular regulation in eumenorrheic women.  
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Chapter Three: Materials and Methodology 
3.1 Ethics and Informed Consent 
 Participation in this experiment was entirely voluntary. The participants were 
informed about the experimental procedures and were aware of the purpose of this study, as 
well as all potential risks associated with participating. All participants provided written 
informed consent prior to partaking in the research. The study was approved by the Massey 
University Human Ethics Committee (SOA 18/77) and conformed to the Declaration of 
Helsinki. 
3.2 Participants 
 Based on results from Abidi et al. (2017) of low and high sex hormone effect on middle 
cerebral artery blood flow the effect sizes were calculated, with significance (alpha) set to 
p=0.05 (5%) and ß set at 90%. Using the tables from Thomas, Nelson, and Silverman (2001, 
pp 118), the sample size estimated to 12. Allowing for up to 20% drop out the total number 
of participants to be recruited is 14. A total of 10 healthy female individuals (mean ± SD: age, 
28 ± 7 years; height 168 ± 6 cm, weight 75 ± 19 kg, BMI 26 ± 6 kg/m2) were recruited for the 
study. However, data was reported for seven participants as one withdrew, one did not 
ovulate (see Section 3.7 for ovulatory criteria), and one participant is still currently active in 
the research. All participants were healthy and free of any medical conditions, were not taking 
any form of medication (including any form of oral contraceptives and intrauterine devices), 
were non-smokers, and had no history or symptoms of cardiovascular, pulmonary, metabolic, 
or neurological disease. A general health questionnaire was completed by the participants for 
screening purposes.  
3.3 Experimental Design 
 All participants visited the temperature-controlled laboratory four times, once to 
receive a full familiarisation session of the experimental protocol and three times to complete 
the experimental trial at the different stages of the menstrual cycle. Demonstrations, 
explanations, and potential risks were clarified to the participants during the familiarisation 
session and experimental sessions to ensure a full understanding of the trial. During the 
familiarisation, the participant became familiar with the equipment used for data collection 
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in the trial and the sequence of procedures for the experimental trial. In addition, the 
participant practiced generating a mouth pressure of 40 mm Hg for the VM arm of the study. 
The MCA and posterior cerebral artery (PCA) were insonated using techniques described in 
section 3.4.2. The participants were also given an ovulation kit to track their high oestrogen 
phase (see Section 3.7). The participants could volunteer for the study at any day of the 
menstrual cycle then begin tracking from the last known day 1 (onset of menses). If the 
participant does not remember their last menses, then it was encouraged to start tracking 
from the next menses to avoid any confusion.  The completion of the study was in random 
order, as the first trial for each participant was not always the early follicular phase.  
The familiarisation occurred > 1 week before the tracking period of the experiment. 
Participants arrived at the laboratory having refrained from caffeinated beverages for 12 
hours, and vigorous exercise and alcohol consumption for ≥ 24 hours prior to testing. Once 
consent was gained and the familiarisation session was completed, participants were 
instructed to track their menses for two cycles before their first experimental trial. The 
purpose of tracking menses before the first experimental trial was to determine the length of 
the menstrual cycle and menses as well as the approximate number of day/s high oestrogen 
concentrations occurred. This was done to ensure that when the participants came in for the 
experimental trials, they were in the phase that was intended, and that oestrogen and 
progesterone concentrations were reflective of those phases. The sequence of trials is 
outlined in Figure 7 below.   
 
Figure 7 Experimental trial sequence. The participants first came to the lab for the 
familiarisation session. The trials began after tracking menses. The trials were completed in a 
random order, which is dependent on when during their cycle they entered the study and 
when they began tracking. Early Follicular; EF, Late Follicular; LF, Mid-Luteal; ML.  
Trial 1 
- EF or LF or ML 
- Dependent on Participant 
Trial 2 
- EF or LF or ML 
- Dependent on Participant 
Trial 3 
- EF or LF or ML 




3.4 Measurements of Cerebral Blood Flow velocity, Arterial Blood Pressure, and Heart 
Rate 
3.4.1 Systemic Haemodynamics 
 Heart rate (HR) was measured using a three-lead electrocardiogram (ECG; 
ADInstrument, Australia). Non-invasive beat-to-beat ABP was measured by finger 
photoplethysmography (Finapres Medical Systems, The Netherlands). The cuff was placed on 
the right hand on either the middle finger or the index finger of the participant and referenced 
to the level of the heart using the height correction unit of the machine and was checked 
against a manual sphygmomanometer. Cerebrovascular conductance index (CVCi) was then 
calculated using the equation: 
MCAvmean / MAP  
3.4.2 Middle Cerebral Artery Blood Velocity 
Blood flow velocity in the MCA (MCAv) was measured using transcranial Doppler 
ultrasonography (DWL, Compumedics, Germany). Blood velocity in the M1 segment of the 
MCA was measured using a 2 MHz probe, fixed in position via an adjustable headband. The 
probe was fixed over the temporal window, above the zygomatic arch, known as the trans-
temporal approach using search techniques described elsewhere (Aaslid, Markwalder, & 
Nornes, 1982; Willie et al., 2011). Bathala, Mehndiratta, & Sharma (2013) found that the M1 
MCA is found approximately at the depth of 45 – 60mm. The average depth where MCA was 
found in the current study was 59mm, with a range of 55 – 66mm. Ultrasound gel (Tensive, 
Parker Laboratory, Fairfeild, NY, USA) was placed between the transducer probe and the skin 
to ascertain the highest quality image.  
3.5 Partial Pressure of End-tidal Carbon Dioxide 
 The partial pressure of end-tidal carbon dioxide (PETCO2) was measured using a breath-
by-breath online gas analyser (ADInstruments, Australia) and was collected throughout the 
experimental trial using a nasal cannula. The gas analyser was calibrated to known gas 
concentrations before each experimental trial. PETCO2 was not measured during the VM, as 
the participants were instructed to blow into a tube with a mouth pressure of 40 mm Hg to 
induce the VM. 
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3.6 Data Acquisition 
All data were collected continuously using an analogue to digital converter (PowerLab, 
ADInstruments, Australia) interfaced with a computer and then analysed using the LabChart 
software (v8.1.12 ADInstruments, Australia). 
3.7 Measurement of Oestrogen and Progesterone 
 Participants were instructed to monitor and record key events of their menstrual cycle 
for two cycles prior to the experiment. As seen in Figure 5, to identify if the participant was in 
early follicular (EF), EF was defined as the duration of menses, which included the onset of 
menses to the end (full cessation of menses).  Mid-luteal phase (ML) of the menstrual cycle 
was defined as the midpoint between ovulation and the start of menses. In a 28-day cycle, 
ML would be on day 21, however, due to the length of menstruation being different for all 
individuals, this was calculated using the information gathered from two previous cycles as 
described below. A urinary-based digital ovulation kit that detects both luteinizing hormone 
(LH) and oestrogen concentrations (Clearblue Fertility Monitor, SPD Swiss Precision 
Diagnostics) was given to the participants following menstruation. Participants were 
instructed to use it daily in the morning of the day following the cessation of menstruation 
(see paragraph below for more information). The participant used the ovulation kit until high 
fertility (rise in oestrogen concentration) is indicated on the ovulation kit. Once high fertility 
is identified, participants would record this in reference to the first day of their menstrual 
cycle (onset of menstruation = day 1). The participant continued to use the ovulation kit until 
peak fertility (LH surge) was identified and use of the ovulation kit would cease for that cycle. 
The recorded timings would serve as a guideline for use of the ovulation kit and in preparation 
for the experimental trial. In the next menstrual cycle, two days prior to the estimated onset 
of high oestrogen participants would use the ovulation kit.  Once high fertility was confirmed 
participants were instructed to schedule an appointment that would coincide with their late 
follicular phase. The participant would use the ovulation kit in the morning of the 
experimental trial to confirm high fertility. If the high fertility symbol did not appear on the 
day of the scheduled trial, the trial was postponed until the ovulation kit showed high fertility.     
 The Clearblue Advanced Digital Ovulation Test detects both LH and oestrogen, thus 
providing a larger window for the late follicular phase (high oestrogen) phase. Su, Yi, Wei, 
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Chang, and Cheng (2017) found that both LH urinary ovulation kits and digital monitors kits 
for LH and oestrogen had high accuracy for ovulation, with accuracies of 97% and 95.8 – 97% 
respectively. Furthermore, a study conducted by Tanabe et al. (2001) found that the peak in 
urinary LH detected by the fertility monitor strongly correlated to LH peak detected by 
laboratory assay. Behre et al. (2000) study showed that ovulation was correctly predicted 
within two days of urinary LH peak day in 123 of 135 ovulatory cycles. Urinary-based ovulation 
kits to detect a surge in LH and therefore detect ovulation has been used in many studies 
(Berglund, Hirschberg, & Scherwitzl, 2015; Ceric, Silva, & Vigil, 2005; Fehring, 2002) because 
of the accuracy, cost effectiveness, and non-invasiveness of the test, when compared to 
ultrasonography.  
 Blood samples were also taken from the participants on the day of each experimental 
trial to determine oestrogen and progesterone concentrations and confirm which phase of 
the menstrual cycle that they were in. The defined range for the trials were: EF, oestrogen 
<200 pmol/L; progesterone 0 – 1 nmol/L, LF, oestrogen >201 pmol/L; progesterone 0 – 2 
nmol/L, and ML, oestrogen <120 pmol/L; progesterone >9.5 nmol/L. Hatcher, Breedlove, 
Judy, and Martin (1988) stated that progesterone concentrations over 9.5 nmol/L indicate 
that ovulation has occurred. Therefore, data collected from participants with progesterone 
concentrations below 9.5 nmol/L were excluded, and the participant was required to 
complete a re-trial. The participants were instructed to complete blood sampling = within 1 
hour of the experimental trial. All trials were completed at the same time of day.  
3.7.1 Blood Sample Extraction Method 
 The blood extraction was done by a trained phlebotomist at a Southern Community 
Laboratory (SCL) location in Wellington. The phlebotomist verbally confirmed the participants 
details and the reason for the blood samples. Then the participant was asked to be seated as 
the phlebotomist inspected the participant’s arm for a suitable vein, this is often the medial 
cubital vein located in the antecubital fossa. When the vein had been located, the surface of 
the skin was cleaned with an alcohol wipe. A tourniquet was placed 5 – 10 cm above the site 
of venous puncture to engorge the vein with blood. The blood sample was collected using a 
closed vacutainer system. The needle was inserted into the vein and a yellow serum separator 
tube (SST) was inserted into the vacutainer that allowed self-filling of the blood. Two yellow 
SSTs were collected. Once the blood was collected, the tourniquet was undone with the 
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needle still in place. A cotton swab was placed over the venepuncture site and the needle was 
gently removed. Pressure was applied at the site of venepuncture to stem any bleeding. 
3.7.2 Blood Sample Analysis  
 The blood analysis for oestrogen and progesterone concentrations was completed on-
site using electrochemiluminescence immunoassay analysis, using the Roche Cobas e602 
machine. The results were then emailed to the lead researcher.  
3.8 Experimental Procedures  
 Assessment of dCA was done throughout the VM as it is a manoeuvre that induces 
both hypotensive and hypertensive changes to blood pressure. The intention of using forced 
oscillation in MAP was to increase the power (i.e. MAP) input which would allow for more 
significant analysis of the relationship between BP and MCAv  (Smirl, Hoffman, Tzeng, Hansen, 
& Ainslie, 2015). The experimental design is outlined in Figure 8 below.  
3.8.1 Valsalva Manoeuvre 
 During the VM, the participant was seated and remained seated for baseline 
measures. Once baseline measures were taken, the participant performed the VM by blowing 
in a tube with a mouth pressure of 40 ± 5 mm Hg for 15 s, as described previously by Perry, 
Cotter, Mejuto, Mundel, and Lucas (2014) and Junqueira (2008). The participants had an 
opportunity to practice the VM during the familiarisation and before the VM was performed 
the participants were reminded of what pressure and duration were needed. The pressure 
measure was on the screen in front of the participants so that they were to achieve a mouth 
pressure of 40 mm Hg with real time visual feedback. The gas analyser was turned off during 
this manoeuvre, and the participant was provided with a nose clip to ensure that they were 
performing the VM correctly. HR, MAP and MCAv were measured continuously throughout 
this manoeuvre. Once the VM was performed the gas analyser was turned back on and the 
nose peg was removed, the participant was instructed to breath normally through their nose. 
The participant remained seated until systemic haemodynamic measures returned to 




Figure 8 Experimental Protocol. Each participant completed the sit-to-stand manoeuvre, 
Valsalva manoeuvre, and the thigh cuff occlusion for each trial. Circulatory (MAP and HR) and 
respiratory (PETCO2) variables returned to baseline levels prior to the next intervention. Please 
note for the purposes of this thesis only the Valsalva manoeuvre data was presented.  
3.9 Data Analysis 
3.9.1 Assessment of the dynamic relationship between MAP and MCAv  
Tieck’s AI method was used to assess the dCA in the thesis (also see section 2.2.6.1). 
Two different equations were used to calculate the AI for the VM. The first equation was used 
to calculate dCA during phase II of the VM is as follows: 
  
The equation used to calculate dCA during phase IV of the VM is as follows: 
 
The equation above has been modified from the original calculation from Tiecks et al. (1995), 
as phase I has been replaced with phase III to reflect post strain regulation. Furthermore, the 
magnitude of the response to the strain is being assessed, therefore standardising the 
response using the phase immediately before presents a more valid result. 
Values that are greater than 1.00 indicate that autoregulation is present, while values less 
than 1.00 indicate that autoregulation is absent.  
 
Put on instruments 
- ECG (3 Lead) 
- TCD (MCA & PCA) 
- Finapres (BP) 
- Nasal Cannula (PETCO2) 
 







- Sit for 1 minute then 
stand for 1 minute 
- Repeat 3 times 
 
Valsalva Manoeuvre 
- Mouth pressure at 40 
mm Hg for 15 s 
- Turn gas analyser off 
 
Thigh Cuff Occlusion 
- 5 minutes occlusion 
then release in a seated 
position 







CBFV (phase IIb – phase II a) / CBFV (phase IIb) 
ABP (phase IIb – phase II a) / ABP (phase IIb) 
AI – II = 
CBFV (phase IV) / CBFV (phase III) 
ABP (phase IV) / ABP (phase III) 
AI – IV = 
51 
 
3.9.2 Dependent Measures 
Mean MCAv (MCAvmean) and MAP were calculated by the cardiac cycle divided by the 
pulse interval. The cerebrovascular conductance index (CVCi) for the MCA was calculated by 
using the equation MCAv/MAP. The Gosling pulsatility index (PI) for the MCA was calculated 
via  
𝑠ystolic MCAv (SMCAv)− diastolic MCAv (DMCAv)
MCAvmean
 (Gosling & King, 1974).  
3.10 Statistical Analysis 
All data were analysed using SPSS statistical software version 26 (IBM Corp., Armonk, 
NY, USA). Statistical significance was set at P ≤ 0.05. A one-way analysis of variance (ANOVA) 
was performed to compare baseline measures of all three trials. A repeated measures two-
way ANOVA was used to analyse dependent variables of interest for all conditions (phases x 
trials, 5 x 3). Additionally, the relative changes in MCAv, MAP, and CVCi for all conditions were 
analysed using a repeated measures two-way ANOVA (phases x trials, 5 x 3). The post-hoc 
pairwise comparisons were used to isolate main effects in the data. The Bonferroni correction 
factor was used when necessary. Partial eta square (partial η2) is reported for the interaction 
effect only, with large effect sizes identified as > 0.1379, medium 0.0588 – 0.1379, and small 




Figure 9 Haemodynamic variables for one participant’s 40 mm Hg Valsalva manoeuvre, MCAv; 
middle cerebral artery velocity, MAP; mean arterial pressure, HR; heart rate, and Mouth 
pressure as a surrogate for intrathoracic pressure. Thick black line represents the mean value 















































Chapter Four: Results 
4.1 Baseline Values 
 Baseline cardiovascular and cardiorespiratory measures are shown in Table 1 below. 
All resting values were not different between EF, LF, and ML and yielded no significant 
statistical differences between the trials.   
Table 1 Participant baseline cerebral blood flow and cardiovascular measurements 
Variables Early Follicular Late Follicular Mid Luteal P-value 
MCAvmean (cm/s) 63 ± 13 56 ± 13 62 ± 12 0.635 
MAP (mm Hg) 73 ± 8 66 ± 9 67 ± 14 0.409 
HR mean (bpm) 69 ± 16 73 ± 12 73 ± 13 0.876 
CVCi (cm/s/mm Hg) 0.87 ± 0.18 0.89 ± 0.26 0.89 ± 0.26 0.984 
PI 0.76 ± 0.18 0.77 ± 0.14 0.77 ± 0.14 0.912 
PP (mm Hg) 64 ± 4 65 ± 15 66 ± 7 0.943 
PETCO2 (mm Hg) 42 ± 4 42 ± 3 40 ± 3 0.525 
Data are means ± SD. MCAvmean, mean middle cerebral artery blood flow velocity; MAP, mean arterial pressure; HR, 
heart rate; CVCi, cerebrovascular conductance index; PI, pulsatility index; PP, pulse pressure. 
4.2 Oestrogen and Progesterone Concentrations 
 Ovarian hormone concentrations are shown in Table 2.  
Table 2 Participant sex hormone concentrations and ratio 
Variables Early Follicular Late Follicular Mid Luteal P-value 
Oestrogen (pmol/L) 129 ± 31 485 ± 208 * 425 ± 230 * 0.003 
Progesterone (nmol/L) 1 ± 0 2.2 ± 2 28 ± 13*‡ <0.001 
Progesterone/Oestrogen Ratio 8 ± 2 2 ± 1* 80 ± 47*‡ <0.005 
Data are means ± SD.  *, significantly different from early follicular (P < 0.025). ‡, significantly different 
from late follicular (P ≤ 0.001). 
4.3 Partial Pressure of End-Tidal CO2 
 There were no statistically significant differences in PETCO2 between the first full 
breath taken post VM between EF (40 ± 4 mm Hg), LF (40 ± 4 mm Hg), and ML (40 ± 3 mm Hg, 
P = 0.907).  
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4.4 Cerebrovascular and cardiovascular response to the Valsalva manoeuvre   
Dynamic cerebrovascular and cardiovascular responses to the VM are shown in Table 
3. Additionally, the percentage change from the preceding baseline is shown in Figure 10, and 
autoregulatory indices for phase II and IV are shown in Table 4. Briefly, a significant interaction 
effect for MCAv was identified (P = 0.039). MCAv in phase IIb of the VM was greater for ML 
(58 ± 15 cm/s) compared to EF (51 ± 14 cm/s, P = 0.013) and LF (49 ± 15 cm/s, P = 0.024). No other 
significant interaction effects were found for absolute or relative data (Table 3 and Figure 10, 
respectively).   
Table 3 Cerebrovascular and cardiovascular responses to the Valsalva manoeuvre (VM)  
Variables Trial 
 Valsalva Manoeuvre Phase P-Values Partial η2 
I IIa IIb III IV Trial VM Phase Trial x Phase  
MCAvmean 
(cm/s) 
EF 64 ± 12 43 ± 13 51 ± 14‡ 63 ± 15 89 ± 13 
0.058 <0.0001 0.039 0.274 LF 65 ± 16 39 ± 11 49 ± 15‡ 52 ± 9 74 ± 17 
ML 66 ± 10 44 ± 11 58 ± 15 58 ± 14 82 ± 13 
MAP 
(mm Hg) 
EF 100 ± 22 70 ± 18 82 ± 23 67 ± 12 106 ± 11 
0.206 <0.0001 0.097 0.233 LF 101 ± 11 67 ± 12 79 ± 15 57 ± 11 100 ± 10 
ML 102 ± 17 76 ± 16 94 ± 12 68 ± 8 101 ± 11 
CVCi 
(cm/s/mm Hg) 
EF 0.67 ± 0.21 0.67 ± 0.32 0.68 ± 0.34 0.95 ± 0.21 0.85 ± 0.14 
0.565 <0.0001 0.808 0.085 LF 0.65 ± 0.19 0.58 ± 0.20 0.63 ± 0.19 0.94 ± 0.27 0.74 ± 0.18 
ML 0.66 ± 0.14 0.61 ± 0.20 0.63 ± 0.19 0.92 ± 0.32 0.83 ± 0.19 
HR  
(bpm) 
EF 82 ± 16 96 ± 11 108 ± 12 116 ± 15 94 ± 23 
0.245 <0.0001 0.360 0.159 LF 81 ± 11 93 ± 11 104 ± 9 117 ± 13 81 ± 15 
ML 83 ± 16 92 ± 19 105 ± 16 111 ± 18 79 ± 26 
PI 
EF 0.71 ± 0.20 1.04 ± 0.38 0.54 ± 0.11 0.92 ± 0.53 0.63 ± 0.08 
0.412 0.003 0.354 0.160 LF 0.67 ± 0.14 0.86 ± 0.21 0.58 ± 0.08 0.79 ± 0.23 0.74 ± 0.14 
ML 0.69 ± 0.15 0.94 ± 0.32 0.54 ± 0.10 1.16 ± 0.72 0.73 ± 0.18 
PP 
(mm Hg) 
EF 69 ± 10 47 ± 7 45 ± 7 54 ± 19 84 ± 14 
0.040 <0.0001 0.942 0.055 LF 68 ± 5 45 ± 10 42 ± 10 53 ± 14 88 ± 17 
ML 72 ± 8 57 ± 14 51 ± 8 59 ± 17 92 ± 13 
Data are means ± SD. EF; early follicular, LF; late follicular, ML; mid luteal, MCAvmean, mean middle cerebral artery blood flow velocity; MAP, mean arterial pressure; HR mean, heart rate mean; 
CVCi, cerebrovascular conductance index., PI, pulsatility index; PP, pulse pressure. ‡ Statistically significant difference in this VM phase from ML (P <0.025).  
 
 
Figure 10 Mean middle cerebral artery blood velocity (MCAvmean), mean arterial pressure 
(MAP), and cerebrovascular conductance index (CVCi) relative changes from baseline (%). 
Data are means ± SD.  
P-values n = 7 
Trial = 0.934 
Phase <0.0001 
Interaction = 0.071 
Partial η2 = 0.274 
P-values n = 7 
Trial = 0.051 
Phase <0.0001 
Interaction = 0.071 
Partial η2 = 0.274 
P-values n = 7 
Trial = 0.569 
Phase <0.0001 
Interaction = 0.655 
Partial η2 = 0.110 
Table 4 Autoregulatory index 
Variable Trial Mean ± SD P-Values 
AI-II 
EF 2.14 ± 2.16 
0.354 LF 1.78 ± 0.85 
ML 1.07 ± 0.55 
AI-IV 
EF 0.90 ± 0.12 
0.086 LF 0.81 ± 0.11 
ML 0.96 ± 0.11 
Data are means ± SD. AI; Autoregulatory Index. The AI scale range is 0 – 9, the greater the value is over 1, the greater CA. AI 
– II; autoregulatory index for phase II (initial strain regulation) , AI – IV; autoregulatory index for phase IV (post strain 
regulation); EF, early follicular; LF, late follicular; ML, mid luteal.    
 
Chapter Five: Discussion 
 The aim of this study was to investigate the effects of oestrogen on cerebrovascular 
regulation in eumenorrheic women. The main findings from the present study are that the 
MCAv response to the VM varied throughout the menstrual cycle. A greater phase IIb MCAv 
was observed in ML compared to EF and LF. There were no statistically significant differences 
in resting cerebrovascular haemodynamics measures during rest across the menstrual cycle 
and are in agreement with Favre and Serrador (2019). Indices of cerebrovascular function 
(e.g. AI, Table 4) and blood pressure were also trending towards significance. Importantly, 
plasma hormone concentrations corroborated the expected position of the participants 
within the menstrual cycle. These data indicate that it is probable that circulating ovarian 
hormones modulate the cerebrovascular response to dynamic blood pressure challenges.  
5.1 Plasma Ovarian Hormone Measures 
 As seen in Table 2, there were significant differences in ovarian hormone 
concentrations and progesterone to oestrogen ratio across the menstrual cycle, confirming 
the position of the participants within their cycle(Figure 5). Others investigating dCA across 
the menstrual cycle did not include the LF phase (Abidi et al., 2017) or measured salivary 
ovarian hormone concentrations (Favre & Serrador, 2019). Favre and Serrador (2019) 
reported no significant change in salivary oestrogen despite targeting similar timing across 
the menstrual to this study (EF, LF and ML).  Despite progesterone having a larger influence 
on the vascular tree due to its ability to offset the vasodilatory effects of oestrogen (see 
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Section 2.14) (Miller & Vanhoutte, 1991; Willekes, Hoogland, Keizer, Hoeks, & Reneman, 
1999)there were no significant differences in resting arterial blood pressures or MCAv across 
the menstrual cycle. Furthermore, as seen in the current study, participants ovarian hormone 
concentrations can vary, and they may not ovulate during their cycle. Indeed, two participants 
had to repeat the ML trial as progesterone concentrations did not meet the ≥9.5 nmol/L 
criteria for ovulation (Hatcher et al., 1988). Given the variability demonstrated in the current 
study, and lack of measurement sensitivity in previous reports, it is paramount plasma 
oestrogen and progesterone are measured to confirm the menstrual cycle phase and also if 
ovulation has occurred. The present study was able to determine the correct phase of the 
menstrual cycle that the participant was in during the time of the experimental trial, thus 
enabling a ‘true’ response to the cerebrovascular challenges. 
5.2 Cerebrovascular Regulation during the Valsalva manoeuvre  
The results of the present study found that MCAv was impacted by the different 
concentrations of sex hormone levels, as indicated during phase IIb of the VM. The results did 
in part agree with the hypothesis of the study, which stated that cerebrovascular regulation 
would have a diminishing response. There were no significant differences in autoregulatory 
index values, however, the results for phase IV was trending towards significance (P = 0.084). 
Similarly, there was a trend for differences in MAP in our data. Given the large interaction 
effect size of MAP (Partial η2 =0.233) it is likely that the study is underpowered (see 
limitations). Albeit non-significant, the MAP during ML phase IIb is likely to contribute to the 
elevated MCAv, due to the relationship between the two variables (see Section 3.9.2). As VM 
mouth pressures were standardised, and completed in the seated position, the increase in 
intracranial pressure (ICP) would be expected to be similar. Thus, an increase in MAP during 
the VM would raise cerebral perfusion pressure (CPP, see Section 2.1).  AI is seen to 
counteract changes in phase II better than phase IV, due to the slower and lower magnitude 
change in MAP. CA does not work instantaneously (Aaslid et al., 1989; Tiecks et al., 1995) and 
that there is a ~5 s lag before a vascular response (Zhang et al., 1998). CA is a mechanism that 
interplays with a multitude of factors; therefore, it is difficult to isolate the exact factor that 
is altering CA response. Furthermore, Labrecque et al. (2017) stated that a multiple indices 
approach of assessing dCA is required to improve physiological understanding of dCA and to 
indicate modified function.  
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 Our study showed a differential MCAv response during the VM, which indicates that 
cerebrovascular regulation may be altered by ovarian hormones concentrations. Few studies 
have investigated the menstrual cycle and cerebrovascular regulation. Favre and Serrador 
(2019) and Abidi et al. (2017), concluded that the menstrual cycle does not alter 
cerebrovascular regulation, which is a contrast to the results we obtained, which shows that 
the menstrual cycle does modify the response to BP challenges. Our study showed that during 
ML, when both oestrogen and progesterone was high, there was an increase in phase IIb 
MCAv. This finding is difficult to interpret given it is the only phase where post hoc test 
revealed significance and AI was unchanged. Furthermore, our results may differ from Favre 
and Serrador (2017) and Abidi et al. (2017) due to our smaller sample size. Analysis of other 
VM phases, whilst only trending toward significance, LF phase III and IV MCAvmean remain 
lower than both EF and ML. Furthermore, MAP was ~10 mm Hg lower during phase III in LF 
and aligns with lower MCAvmean values at this time.   As similar post strain PETCO2 values were 
observed it is possible that a larger sample size may reveal a significant difference in the MAP 
response across a number of phases in the VM during LF. Additionally, ovarian hormones may 
also vasodilate the basal arteries of the brain (Krejza et al., 2001; Krejza et al., 2004; Krejza et 
al., 2003) and artificially lower cerebral flow velocities (see limitations Section).  
5.3 Cerebrovascular Regulation: Comparisons with existing data 
The present study, however, challenges previous notions, as the study has found that 
fluctuating hormone concentrations may affect cerebrovascular response to known 
challenges. Favre and Serrador (2019) investigated the effects of blood pressure changes 
using the sit-to-stand manoeuvre and the repeated squat-to-stand manoeuvres across the 
menstrual cycle. The results from Favre and Serrador (2019) showed that there were no 
significant differences in MCAv between EF, LF, and ML (P = 0.116). Furthermore, as 
mentioned in Section 5.1, Favre and Serrador (2019) did not identify any changes in sex 
hormone concentrations in saliva, while the current study plasma oestrogen and 
progesterone concentrations corroborate the tracking data and confirmed the position of the 
participants within their cycle (Table 2).  
  Abidi et al. (2017) reported that the menstrual cycle did not have a significant effect 
on cerebral autoregulation during the VM and sit-to-stand. However, the authors only 
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investigated the low hormone (EF) and high hormone (ML) phases of the menstrual cycle. 
Similar to our study, Abidi et al. (2017) used the VM to induce blood pressure changes in their 
participants, however, only phase II was investigated. Investigating all phases would have 
allowed for the comparison of the different stages as well as examination of the decreases in 
blood pressure. Moreover, Brassard, Ferland-Dutil, et al. (2017) identified that the brain is 
superior at counteracting hypertensive challenges to CA. Therefore, a more pronounced 
effect of female sex hormone on CA could have been identified in phase IIa and phase III of 
the VM. However, this opportunity was missed as Abidi et al. (2017) decided to exclude 
analysis of the other phases of the VM.  
5.4 Future Considerations and Limitations 
 Future studies investigating the effects of female ovarian hormones on cerebral 
regulation should consider examining both the MCA and PCA to identify if regional variation 
in regulation exist in the brain, as indicated for CO2 (Sato et al., 2012). Furthermore, 
understanding how CA reacts to spontaneous fluctuations and forced oscillations in ABP. It is 
possible that “stressed function” may be altered whilst resting absolute values remain 
unchanged. Moreover, as mentioned by Labrecque et al. (2017) there is a need for multiple 
assessments in order to identify any functional changes that occur to dCA.  As mentioned in 
Section 2.7, there is no gold standard when it comes to measuring cerebral autoregulation. 
Some argue that forced oscillations allows for more robust results to be analysed and it 
reflects the strains of everyday activities (Claassen et al., 2009; Simpson & Claassen, 2018; 
Tan, 2012).  However, others say spontaneous fluctuations should be the main method as CA 
would be most effective in this range and forced oscillations would induce an autonomic 
response (Tzeng & Panerai, 2018; Zhang et al., 1998). Therefore, the incorporation of both 
forced oscillations and spontaneous fluctuations in research is needed. Multiple methods of 
perturbing MAP (sit-to-stand and thigh cuff occlusion) were employed in this study as part of 
a broader research question, however, only the forced oscillation induced by the VM are 
reported in this thesis. The significant effects of VM phase reported in the two-way ANOVA, 
indicate that the intervention was successful in producing forced oscillations in MAP. 
Moreover, this study showed the importance of obtaining sex hormone concentrations 
through blood sampling. The use of this technique will ensure more reliable results which is 
pivotal for timing in research looking at the effects of female ovarian hormones. 
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 We acknowledge that there are some limitations in the study that should be 
addressed. We used transcranial Doppler ultrasound to measure cerebral blood velocity in 
our participants. The assumption with using the TCD is that the diameter of the vessel of 
interest remains unchanged throughout. However, it has been reported that there is a <4% 
change in vessel diameter during little changes in MAP (30 ± 16 mm Hg) (Giller, Bowman, 
Dyer, Mootz, & Krippner, 1993).  Furthermore, using high resolution magnetic resonance 
imaging (MRI), Verbree et al. (2014) found that MCA diameter increases in response to 
hypercapnia. Additionally, it has been suggested that sympathetic activation during isometric 
hand grip exercise is responsible for a reduction in MCA diameter (Verbree et al., 2017). 
Therefore, the results from this study will need to be validated through other cerebral blood 
flow techniques.  Moreover, as previously mentioned in Section 5.2, changing ovarian sex 
hormone concentrations cause dilation of basal arteries, further emphasising the need for 
other methods of measuring CBF.  Furthermore, a limitation of this study includes the 
difficulties of accurately measuring arterial PCO2 levels as the VM consists of performing a 
breath hold. PETCO2 cannot be used as an accurate measure of arterial CO2 as a VM correlates 
to a significant reduction in cardiac output and therefore, a decreased washout of CO2 in the 
tissue (Meyer, Gotoh, Takagi, & Kakimi, 1966). Moreover, there is a delay of ~6 s for a 
response in MCAvmean to be observed (Pott et al., 2000). However, as mentioned above in 
Section 2.14, a decrease in PaCO2 contributes to the 10 – 15% decrease in MCAv during a 15 
s VM (Pott et al., 2000), therefore, accurate measures of PaCO2 is of great importance in 
identifying any significant changes in MCAv seen. 
As alluded to in the preface, conducting a study looking at the effects of ovarian sex 
hormones on cerebrovascular regulation posed a significant challenge. Recruitment of 
participants was difficult as most female university students were using oral contraception or 
an intra-uterine device. The study initially had 10 participants. However, due to participant 
withdrawal, equipment availability and the COVID-19 pandemic, participant numbers were 
reduced to seven for the analysis. The reduction in numbers for analysis underpowered some 
aspects of the study, as the interaction effect of VM phase and trial for MAP showed a trend. 
Individual variability in cycle length, and frequency of ovulation, meant on several occasions 
trials had to be repeated on the next cycle, despite a rigorous tracking schedule. Furthermore, 
hormone concentrations were not available to the researchers until following the 
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experimental trial. Phlebotomy and blood analysis were outsourced to SCL Wellington. The 
laboratory has limited opening hours which hampered data collection outside the working 
week.   
Chapter Six: Conclusion 
6.1 Conclusion 
 The results from this study show that there are small differences in the 
cerebrovascular response to the VM across the menstrual cycle. The method of challenging 
cerebrovascular regulation through the VM produced both hypertensive and hypotensive 
changes to blood pressure. We suggest that future studies investigate additional methods of 
challenging CA as the VM does not allow for the measurement of CO2 which is a known potent 
regulator of CA. Furthermore, including data from PCA to identify if the response is 
heterogeneous throughout the brain is warranted. Moreover, this study only looked at forced 
oscillations in ABP when spontaneous fluctuations in ABP also occurs. Future studies should 
include both forced and spontaneous oscillations when investigating CA, to further 
understand the mechanisms that contribute to CA and the responses to different types of 
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